Haemolytic Anaemia

| Home | | Pharmacovigilance |

Chapter: Pharmacovigilance: Nomifensine and Haemolytic Anaemia

Drug-induced haemolytic anaemia results from a type II immune reaction in which antibodies to the drug or its metabolite(s) attack blood cells.


HAEMOLYTIC ANAEMIA

Drug-induced haemolytic anaemia results from a type II immune reaction in which antibodies to the drug or its metabolite(s) attack blood cells. Antigens on the cell’s surface combine with antibody and complement to stress the cell to the point of destruc-tion. The cell damage causes anaemia. There is an increased production of bilirubin, although a healthy liver can excrete six times the normal load before unconjugated bilirubin accumulates in the plasma; jaundice is therefore mild. Severe haemolysis can result in prerenal uraemia and renal failure.

Contact Us, Privacy Policy, Terms and Compliant, DMCA Policy and Compliant

TH 2019 - 2022 pharmacy180.com; Developed by Therithal info.